Blood-brain barrier dysfunction and recovery (Q36426867)

14 August 2017

1 reference

title

Blood-brain barrier dysfunction and recovery (English)

1 reference

14 August 2017

1 reference

A G de Boer

1

1 reference

PubMed ID

16550324

14 August 2017

P J Gaillard

series ordinal

2

1 reference

14 August 2017

1 April 2006

1 reference

Journal of Neural Transmission

14 August 2017

1 reference

14 August 2017

113

1 reference

14 August 2017

455-462

1 reference

14 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s00702-005-0375-4

14 August 2017

0 references

cites work

The expression of microfilament-associated cell-cell contacts in brain endothelial cells is modified by IFN-beta1a (Rebif).

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00702-005-0375-4

Tumour necrosis factor-alpha causes an increase in blood-brain barrier permeability during sepsis.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00702-005-0375-4

HIV-1 infection of human brain-derived microvascular endothelial cells in vitro

21 January 2018

1 reference

12 December 2020

Interferon-alpha 2b enhances barrier function of bovine retinal microvascular endothelium in vitro

1 reference

12 December 2020

An experimental and ultrastructural study on the development of the avian choroid plexus

1 reference

12 December 2020

Regulation of a blood-brain barrier-specific enzyme expressed by cerebral pericytes (pericytic aminopeptidase N/pAPN) under cell culture conditions.

1 reference

12 December 2020

Cerebrovascular permeability changes during experimental meningitis in the rat.

1 reference

12 December 2020

Development of the embryonic vascular system.

1 reference

12 December 2020

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

12 December 2020

Transendothelial permeability changes induced by free radicals in an in vitro model of the blood-brain barrier

1 reference

12 December 2020

Immunology of multiple sclerosis

1 reference

12 December 2020

Pathogenesis and pathophysiology of bacterial meningitis

1 reference

12 December 2020

The role of drug transporters at the blood-brain barrier

1 reference

12 December 2020

Effect of inflammatory agents on electrical resistance across the blood-brain barrier in pial microvessels of anaesthetized rats.

1 reference

12 December 2020

An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro.

1 reference

12 December 2020

Differentiation of endothelial cells: analysis of the constitutive and activated endothelial cell phenotypes

1 reference

12 December 2020

Glucocorticoid and type 1 interferon interactions at the blood-brain barrier: relevance for drug therapies for multiple sclerosis

1 reference

12 December 2020

Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug

1 reference

12 December 2020

Astrocytes induce blood–brain barrier properties in endothelial cells

1 reference

12 December 2020

Hydrocortisone reinforces the blood-brain properties in a serum free cell culture system

1 reference

12 December 2020

Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro

1 reference

12 December 2020

Increased blood-brain barrier permeability in LP-BM5 infected mice is mediated by neuroexcitatory mechanisms

1 reference

12 December 2020

Characterization of an in vitro blood-brain barrier model system for studying drug transport and metabolism.

1 reference

12 December 2020

Altered blood-brain-barrier function in Alzheimer's disease?

1 reference

12 December 2020

Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier

1 reference

12 December 2020

Pharmacological investigations on lipopolysaccharide-induced permeability changes in the blood-brain barrier in vitro

1 reference

12 December 2020

Emerging treatments in multiple sclerosis

1 reference

12 December 2020

Interleukin-1beta -induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: a magnetic resonance study.

1 reference

12 December 2020

Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group

1 reference

12 December 2020

Transport of a hydrophilic compound into the cerebrospinal fluid during experimental allergic encephalomyelitis and after lipopolysaccharide administration.

1 reference

12 December 2020

Inflammatory events at the blood brain barrier: regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species

1 reference

12 December 2020

Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes.

1 reference

12 December 2020

10.1007/S00702-005-0375-4

Identifiers

DOI

1 reference

release_aavhcki635ftnbg6ffkkr2fjsm

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/aavhcki635ftnbg6ffkkr2fjsm

24 November 2022

mapped directly with Wikidata item

PubMed ID

16550324

1 reference

PubMed ID

16550324